Meperidine (Demerol) Market is poised to reach US$ 2,784.3 - GlobeNewswire

-

SEATTLE, May 05, 2020 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global meperidine (Demerol) market is estimated to be valued at US$ 2,089.1 Mn in 2020, and is expected to exhibit a CAGR of 4.2% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Meperidine (Demerol) Market:

Meperidine (Demerol) is used as a pain reliever in post-operative pain management, which is expected to support growth of the injectable meperidine. This is also expected to increase demand for meperidine injection sold through hospital pharmacies as it would be sold in the hospitals through this channel. Manufacturers such as Hikma Pharmaceuticals offer injectable forms of the opioid meperidine.

Request for Sample PDF copy @ https://www.coherentmarketinsights.com/insight/request-sample/3816

Moreover, meperidine offers advantages over other opioids such as lesser risk of addiction, and safer than morphine. Due to its short duration of action and limited analgesia or anesthetic effect, it may be effective as an opioid of choice for minimally invasive surgeries.

Moreover, in 2015, Validus Pharmaceuticals LLC (Validus), together with Wood Creek Capital Management, LLC acquired U.S. rights to product lines from Sanofi US which include Demerol (meperidine hydrochloride) tablets. Presence of generic versions of the drug in the market have supported the growth of the segment over the past few years. Manufacturers such as Teva Pharmaceuticals, Hikma Pharmaceuticals, and others offer generic meperidine in the market. Generic meperidine is pharmacologically equivalent to Demerol, and is cost effective than brand Demerol as well.

Apart from this, reimbursement offered by private insurance companies as well as government insurance (Medicare) has supported growth of the U.S. market. For instance, spending on meperidine through Medicare is on the rise for the past few years according to Medicare Part D spending data. These factors are expected to support the North America meperidine (Demerol) market growth during the forecast period.

Read Report Summary @ https://www.coherentmarketinsights.com/market-insight/meperidine-market-3816

Global meperidine (Demerol) Market: Restraints
The major factor restraining the market growth is the presence of alternative potent opioid medications, and risk of side effects such as accumulation of the toxic metabolite normeperidine and possible generalized seizures associated with meperidine.

Key Market Takeaways:

  • The market is expected to exhibit a CAGR of 4.2% during the forecast period (2020-2027). This growth is attributed to the increasing number of surgeries, approvals of meperidine (Demerol) products, and the rising demand for opioid medications in pain management.
  • Injectable meperidine is expected to witness significant growth during the forecast period owing to the increasing use of the drug in managing post-operative pain.

Key players operating in the global meperidine (Demerol) market are—

  • Pfizer, Inc.,
  • Hikma Pharmaceuticals USA Inc.,
  • Epic Pharma, Inc.,
  • Teva Pharmaceutical Industries Ltd.,
  • Vintage Pharmaceuticals, Inc.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3816

Market Segmentation:

  • Global Meperidine (Demerol) Market, By Dosage Form:
    • Tablet
    • Injection
    • Syrup
  • Global Meperidine (Demerol) Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  •  Global Meperidine (Demerol) Market, By Region:
  • North America
    • U.S.
    • Canada
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Central Africa
    • South Africa
    • North Africa

Related Topics:

EYE HEALTH SUPPLEMENTS MARKET

Eye health supplements are pharmaceutical preparations used in maintaining eye health. Antioxidants such as Lutein and Zeaxanthin of the carotenoid family are some of the eye health ingredients. Use of antioxidants as eye health ingredients is expected to grow steadily over the forecast period. Increase in number of eye health supplements is also projected to enhance the growth of eye health ingredients market during the forecast period.

Read more @ https://www.coherentmarketinsights.com/market-insight/eye-health-supplements-market-3791

HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET

Healthcare Contract Research Outsourcing is conducted by pharmaceutical and medical device sectors for development of new drugs and medical devices. Clinical trials form the key part of pharmaceutical drug and medical device development and in the current scenario clinical trials are conducted across multiple locations in various geographies.

Read more @ https://www.coherentmarketinsights.com/market-insight/healthcare-contract-research-outsourcing-market-3788

Comments

Post a Comment

Popular posts from this blog

Manual on meat inspection for developing countries

-
Image
sinusitis treatment :: Article Creator My 'sinus Infection' Turned Out To Be A One In A Million Nasal Cancer At Just 28 - And Doctors Had To Cut My Eye Out To Save Me By Emily Joshu Health Reporter For Dailymail.Com Published: 06:33 EDT, 20 April 2024Updated: 06:35 EDT, 20 April 2024 A 28 year-old California woman has described the shock of being diagnosed with a deadly sinus cancer that affects fewer than one in a million people - and led to the removal of her right eye. The 'golf ball-sized tumor', which had spread throughout her face, was first mistaken for a sinus infection by the woman's doctors.  Annika, who posts about her condition on TikTok, woke up one morning in 2023 and noticed that the inner corner of her right eye was sore.  While she at first thought nothing of it, by the time the evening rolled around, 'my face started to really, really hurt on the right side,' she said in a video.  The next day, her
Read more

Rash behind ear: Causes, other symptoms, and treatment - Medical News Today

-
Image
A rash behind the ear may occur due to a variety of different medical conditions. Certain viral infections and autoimmune diseases may cause a rash behind the ear in both children and adults. While some causes, such as contact dermatitis, are not concerning, other causes, including rubella, may be more serious. In this article, we look at some of the causes of a rash behind the ear, as well as the other symptoms that they may produce and how to treat them. Contact dermatitis is an allergic reaction to a particular substance. If an allergy-inducing substance comes into contact with the skin behind the ear, a rash can form. Allergens that may cause contact dermatitis behind the ears include: shampoos soaps other hair care products For example, hair dye products contain an ingredient called paraphenylenediamine (PPD), which is a common contact allergen. Symptoms Contact dermatitis causes itchiness, dryness, and flaking of the skin that came into contact with the allergen. Diagnosis A doc
Read more

Having This One Particular Blood Type Can Help Protect You From Severe Malaria - ScienceAlert

-
Image
Nearly  half the world's population is at risk of malaria, one of the most deadly diseases known to humankind. Each year it claims  over 400,000 lives, most of whom are children younger than age five. While it's possible to vaccinate against malaria, virtually all of these cases are in the African region, where protection is often nothing more than a roll of the dice. Now, a recent  analysis  of 23 papers suggests those with blood type O have the genetic odds stacked in their favour. In sub-Saharan Africa, where severe malaria - caused by the  Plasmodium falciparum  parasite  - is endemic, there are far more individuals with blood type O than anywhere in Europe or the US. In Nigeria alone, where 97 percent of the country is at risk of malaria, more than half the population belongs to this blood group. In Ethiopia and many others, the numbers are similar. Rather than a coincidence, co-author and epidemiologist Abraham Degarege Mengist from Robert Stempel College of Publi
Read more